Oncology News

In this edition, cross-border partnership takes on survival gap for children with leukemia; ‘paradigm shift’ in transfusion-dependent myelodysplastic syndrome; FDA approves Ayvakit for mastocytosis and more.

Physicians listen to the patient in front of us. We care for one patient at a time. There is inherent individualization in the patient interaction. Each story is unique. Each treatment plan is tailored.

Women with breast cancer whose BMI fell in the overweight or obese ranges achieved meaningful weight loss via a telephone-based intervention, according to phase 3 study results.

CHICAGO — Colorectal cancer screening rates at federally qualified health centers were significantly higher in states that expanded Medicaid under the Affordable Care Act vs. states that did not, according to data at Digestive Disease Week.

Population genomic screening for Lynch syndrome, familial hypercholesterolemia and hereditary breast and ovarian cancer may be cost-effective for adults aged younger than 40 years if the cost is “relatively low,” researchers reported.

In this episode, host Shikha Jain, MD, speaks with Ken Bloom, MD, FCAP, about developing technologies to assist cancer analysis and pathology, the spatial component of antibody conjugates and more.

In this edition, we bring you a deep dive on a collaboration that aims to accelerate better treatments for pediatric cancers.

Cervical cancer screening rates are low across the board, but disparities for Black patients persist, according to researchers.

President Joe Biden today announced his intention to nominate NCI director Monica M. Bertagnolli, MD, FACS, FASCO, as director of the NIH.

The American College of Radiology, or ACR, updated its guidance to recommend that all women receive a breast cancer risk assessment by the age of 25 years to determine if screening is needed earlier than age 40 years.